Cohort PLC (GB:CHRT)
LSE:CHRT
Top Page
Cohort plc
(LSE:CHRT)
Select Model
Select Model
Rating:74Outperform
Price Target:
1,360.00 p
▲(43.31% Upside)
Action:UpgradedDate:03/14/26
The score is driven primarily by strong financial performance (high revenue growth and a solid, conservatively leveraged balance sheet). Technicals are supportive due to trend strength and positive MACD, but overextended RSI/Stoch readings add near-term risk. Valuation is a drag given the higher P/E and modest dividend yield.
Positive Factors
Robust revenue growth
Cohort's ~19% top-line growth reflects durable demand for defence systems and services. Over a multi-month horizon, expanding revenues indicate successful programme wins and market positioning with government customers, supporting scale, longer-term backlog and higher recurring support revenues.
Negative Factors
Weak EPS trajectory
Negative EPS growth suggests earnings per share face compression despite revenue gains, possibly from margin mix, one-off items or dilution. If persistent, lower EPS growth can limit capital allocation flexibility and shareholder returns over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Robust revenue growth
Cohort's ~19% top-line growth reflects durable demand for defence systems and services. Over a multi-month horizon, expanding revenues indicate successful programme wins and market positioning with government customers, supporting scale, longer-term backlog and higher recurring support revenues.
Read all positive factors
Cohort plc (CHRT) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£580.28M
Dividend Yield1.58%
Average Volume (3M)178.03K
Price to Earnings (P/E)25.0
Beta (1Y)1.03
Revenue Growth23.91%
EPS Growth-14.66%
CountryUK
Employees1,400
SectorIndustrials
Sector Strength72
IndustryAerospace & Defense
Share Statistics
EPS (TTM)0.16
Shares Outstanding47,006,740
10 Day Avg. Volume200,080
30 Day Avg. Volume178,030
Financial Highlights & Ratios
PEG Ratio1.65
Price to Book (P/B)3.69
Price to Sales (P/S)2.17
P/FCF Ratio15.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.59
Revenue Forecast (FY)£293.98M
Cohort plc Business Overview & Revenue Model
Company Description
Cohort plc, through its subsidiaries, provides various products and services in defense and security markets in the United Kingdom, Germany, Portugal, Africa, North and South America, and other European countries. The company offers electro-optica...
How the Company Makes Money
Cohort makes money mainly by delivering defence and security programmes and services to government and prime-contractor customers, generating revenue from contracted project work and ongoing support. Key revenue streams typically include: (1) equi...
Cohort plc Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
78
Positive
Cash Flow
75
Positive
| Breakdown | TTM | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 280.62M | 270.04M | 202.53M | 182.71M | 137.76M | 143.31M |
| Gross Profit | 79.19M | 90.42M | 76.27M | 64.86M | 56.60M | 53.36M |
| EBITDA | 34.40M | 35.57M | 29.25M | 23.07M | 21.79M | 21.36M |
| Net Income | 18.26M | 19.25M | 15.32M | 11.36M | 9.20M | 5.46M |
Balance Sheet | ||||||
| Total Assets | 413.94M | 396.58M | 252.50M | 210.69M | 203.17M | 190.88M |
| Cash, Cash Equivalents and Short-Term Investments | 53.16M | 74.65M | 55.16M | 41.45M | 40.37M | 32.29M |
| Total Debt | 95.13M | 78.88M | 40.51M | 34.98M | 39.52M | 37.38M |
| Total Liabilities | 247.03M | 236.49M | 142.66M | 110.91M | 113.98M | 105.83M |
| Stockholders Equity | 165.48M | 158.61M | 108.67M | 97.02M | 83.97M | 79.31M |
Cash Flow | ||||||
| Free Cash Flow | -27.65M | 38.00M | 16.36M | 11.29M | 17.52M | 14.97M |
| Operating Cash Flow | -10.79M | 51.18M | 23.02M | 16.52M | 19.52M | 16.22M |
| Investing Cash Flow | -89.57M | -93.65M | -6.16M | -6.11M | -2.37M | -2.54M |
| Financing Cash Flow | 69.18M | 46.18M | -16.92M | -10.57M | -8.70M | -1.55M |
Cohort plc Technical Analysis
Neutral
949.00
Price Trends
1239.52
Positive
1148.39
Positive
1253.73
Positive
Market Momentum
1.20
Negative
50.28
Neutral
72.61
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CHRT, the sentiment is Neutral. The current price of 949 is below the 20-day moving average (MA) of 1272.10, below the 50-day MA of 1239.52, and below the 200-day MA of 1253.73, indicating a neutral trend. The MACD of 1.20 indicates Negative momentum. The RSI at 50.28 is Neutral, neither overbought nor oversold. The STOCH value of 72.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:CHRT.
Cohort plc Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £2.96B | 19.41 | 16.69% | 1.27% | 0.84% | -62.73% | |
74 Outperform | £580.28M | 24.99 | 11.27% | 1.58% | 23.91% | -14.66% | |
69 Neutral | £64.32B | 11.77 | 17.90% | 1.99% | 11.60% | 8.03% | |
68 Neutral | £6.20B | 9.88 | 43.22% | 0.56% | 7.36% | 48.93% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | £1.48B | 32.18 | 13.12% | 1.64% | -2.53% | 22.25% | |
58 Neutral | £2.49B | 20.00 | -35.50% | 2.00% | -4.59% | -256.51% |
* Industrials Sector Average
GB:CHRT
Cohort plc
1,262.00
109.11
9.46%
GB:BA
BAE Systems
2,194.00
533.09
32.10%
GB:BAB
Babcock International
1,257.50
545.87
76.71%
GB:CHG
Chemring
546.00
164.70
43.20%
GB:SRP
Serco Group plc
297.00
138.10
86.90%
GB:QQ
QinetiQ
477.10
93.14
24.26%
Cohort plc Corporate Events
Regulatory Filings and Compliance
Cohort CEO updates ISA holdings in routine director share transactions
Neutral
Apr 10, 2026
Cohort plc has disclosed director share dealings involving chief executive Andrew Thomis and his person closely associated, Yasmin Thomis, who executed “Bed and ISA” transactions on 9 April 2026. The pair sold and repurchased small vol...
Business Operations and StrategyRegulatory Filings and Compliance
Cohort Updates Block Listing as Employee Share Options Reduce Available Pool
Positive
Apr 2, 2026
Cohort plc has reported its latest six-month block listing return for its 2016 Savings Related Share Option Scheme, covering the period from 2 October 2025 to 1 April 2026. Over the period, 26,859 new shares were issued or allotted under the schem...
Regulatory Filings and Compliance
Cohort Updates Share Capital and Voting Rights Structure
Neutral
Apr 1, 2026
Cohort plc, the AIM-quoted defence technology group, has operations in the UK, Australia, Germany and Portugal, where its seven subsidiaries supply advanced communications, surveillance, sonar, and related systems to defence, security, government ...
Business Operations and StrategyFinancial Disclosures
Cohort’s EID Wins €42.3m Portuguese Navy Communications Contract
Positive
Mar 26, 2026
Cohort’s Portuguese subsidiary EID has secured a €42.3m contract to supply Integrated Communication Systems and networks for the Portuguese Navy’s new fleet, including supply and offshore patrol vessels, with deliveries running t...
Business Operations and StrategyFinancial Disclosures
Cohort’s EM Solutions Wins AU$21.7m Portuguese Navy Satcom Deal
Positive
Mar 23, 2026
Cohort’s Australian subsidiary EM Solutions has secured a AU$21.7m contract to supply its Cobra and King Cobra satellite communications terminals to the Portuguese Navy as part of mid-life upgrades to Vasco da Gama-class frigates and several...
Regulatory Filings and Compliance
Cohort updates market on total voting rights and share capital
Neutral
Mar 2, 2026
Cohort plc has confirmed that as of 28 February 2026 its issued share capital comprises 46,994,682 ordinary shares of 10 pence each, with each share carrying one voting right. The company holds no shares in treasury, and the published share count ...
Business Operations and StrategyRegulatory Filings and Compliance
Cohort updates share option plan block listing and highlights global defence tech footprint
Neutral
Feb 25, 2026
Cohort plc, an AIM-listed defence technology group based in Reading, Berkshire, operates seven specialist businesses in the U.K., Australia, Germany and Portugal. The group focuses on communications, intelligence, sensors and effectors, providing ...
Dividends
Cohort Directors Boost Stakes via Dividend Reinvestment
Positive
Feb 20, 2026
Cohort plc has disclosed that its chief executive, Andrew Thomis, and finance director, Simon Walther, have increased their holdings in the company through automatic reinvestment of interim dividend payments. Following these transactions, Thomis a...
Executive/Board ChangesRegulatory Filings and Compliance
Cohort grants long-term share award to new chief operating officer
Neutral
Feb 16, 2026
Cohort plc has granted a restricted share award to its newly appointed Chief Operating Officer, Christopher Axcell, as part of its executive incentive arrangements. Axcell, who joined the group on 6 February 2026, received an award of 4,435 nil-co...
Regulatory Filings and Compliance
Cohort Updates Total Voting Rights Following Share Capital Review
Neutral
Feb 2, 2026
Cohort plc has reported that, as at 31 January 2026, its issued share capital comprised 46,983,433 ordinary shares of 10 pence each, all carrying one vote per share, with no shares held in treasury. This updated total voting rights figure serves a...
Business Operations and StrategyFinancial Disclosures
Cohort’s MCL Lands £17.9m UK Defence Orders, Securing 2025/26 Revenue Targets
Positive
Jan 30, 2026
Cohort plc has announced that its subsidiary Marlborough Communications Ltd (MCL) has secured new UK defence contracts worth a combined £17.9m, including a £14.0m award from a UK government customer for immediate delivery of uncrewed air...
Business Operations and StrategyFinancial Disclosures
Cohort Publishes Interim Report for Six Months to 31 October 2025
Neutral
Jan 15, 2026
Cohort plc has published its interim report for the six months to 31 October 2025, making the document available to shareholders via post or online through its investor relations website. The release underscores the company’s ongoing disclos...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.